Home » Topics » BioWorld Science

BioWorld Science
RSS

Altamira Therapeutics to develop OligoPhore-based AM-411 for rheumatoid arthritis

July 26, 2022

FDA accepts IND for HOOKIPA's arenaviral immunotherapy HB-300 for metastatic CRPC

July 26, 2022

New CDC7 inhibitors synthesized at Medshine Discovery

July 26, 2022

Sarissa presents new DNA repair protein RAD51 homolog 1 inhibitors

July 26, 2022

Discovery of allosteric mutant-selective EGFR inhibitor for the treatment of NSCLC

July 26, 2022

New SOS-1 inhibitors discovered at Chengdu Baiyu Pharmaceutical

July 26, 2022

Shanghai Institute of Materia Medica identifies new nagilactone derivatives

July 26, 2022

THR-beta agonists described by Shanghai Kunheng Pharmaceutical Technology, Kunming Pharmaceutical

July 26, 2022

Ultra-long-acting dolutegravir prodrug formulation may enhance treatment compliance

July 25, 2022

Androgen receptor-targeting PROTACs synthesized at Arvinas Operations

July 25, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...